Patient-generated health data (PGHD) enhance traditional healthcare by enabling continuous monitoring and supporting personalized care, yet concerns over privacy, security, and integration into existing systems hinder broader adoption. This study examined the perceptions, awareness, and concerns of patients and caregivers regarding PGHD and assessed their willingness to share such data for clinical, research, and commercial purposes. A cross-sectional survey was conducted from 6 to 12 November 2023, involving 400 individuals with experience using PGHD. Participants completed structured questionnaires addressing health information management, PGHD usage, and attitudes toward its application. PGHD was most commonly used by patients with chronic conditions and guardians of minors, with tethered personal health record apps frequently utilized. Respondents identified improved self-management and better access to information as key benefits. However, significant concerns about data privacy and security emerged, especially regarding non-clinical use. Younger adults, particularly those in their 20s, showed lower willingness to engage with PGHD due to heightened privacy concerns. These findings suggest that, while support for clinical use of PGHD is strong, barriers related to trust and consent remain. Addressing privacy concerns and simplifying consent processes will be essential to promote equitable and responsible PGHD utilization across diverse patient populations.

Background/Objectives: Multidrug-resistant (MDR) Gram-negative bacteria represent a significant public health concern worldwide, particularly in resource-limited settings. In Ghana’s Tamale Metropolis, limited data exist on the prevalence and trends of MDR bacteria, posing challenges to effective antimicrobial stewardship. Methods: This study analyzed microbiological data from 2020 to 2023 to address these knowledge gaps. Results: Among the 4859 clinical samples analyzed, 1570 (33.7%) yielded Gram-negative bacterial isolates, with an MDR prevalence of 40.6%. The most frequently isolated organisms were Klebsiella spp. (28.9%) and Escherichia coli (20.4%). Resistance to cephalosporins (51%) and ciprofloxacin (46%) was particularly pronounced, highlighting the diminishing efficacy of commonly used antibiotics. Older adults (aged 60 years and above) presented the highest MDR prevalence, reflecting the vulnerability of this demographic group. Conclusion:These findings underscore the urgent need for enhanced antimicrobial stewardship programs, improved infection prevention and control measures, and continuous resistance monitoring to combat the growing threat of MDR bacteria in the region. Strengthening laboratory capacity and adherence to strict antibiotic usage policies are crucial for reducing the burden of MDR infections and improving patient outcomes.